Exposure to additives or multigrain flour is associated with high risk of work-related allergic symptoms among bakers.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
02 2021
Historique:
received: 11 07 2019
revised: 08 06 2020
accepted: 01 08 2020
pubmed: 29 8 2020
medline: 12 6 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

Wheat flour exposure in bakers can elicit respiratory and skin symptoms. Scarce data are available on the prevalence of such conditions in bakers. We investigated the prevalence of work-related rhinitis, asthma-like symptoms and dermatitis in bakers according to job task and type of allergens involved. Of the 229 traditional bakeries in Verona area who were invited to participate in a cross-sectional survey, 211 (92%) accepted; 727 employees in these bakeries answered a modified version of a questionnaire on job tasks; allergen exposure within the bakery; and work-related nasal, asthma-like and skin symptoms during 2010-2014. Determinants of work-related nasal, asthma-like or skin disorders were separately evaluated using different logistic models. The prevalence of work-related nasal and asthma-like symptoms was, respectively, 15.1% and 4.2% in bakery shop assistants, increasing to 25.7% and 9.5% in bakers using only wheat flour, and further to 31.8% and 13.6% in bakers using flour and additives, and then to 34.1% and 18.2% in bakers using flour with additives and multigrain (p<0.001). The risk of work-related asthma-like symptoms was more than doubled in bakers using additives without or with multigrain than in shop assistants (OR 2.3, 95% CI 1.0 to 5.5 and OR 3.4, 95% CI 1.1 to 10.8, respectively). Making bread with additives alone or with multigrain significantly increased the risk of work-related nasal symptoms in shop assistants, while the risk of skin symptoms was not significantly affected. Bakers using additives alone or with multigrain are at a high risk of experiencing nasal and asthma-like symptoms.

Identifiants

pubmed: 32855346
pii: oemed-2019-106052
doi: 10.1136/oemed-2019-106052
doi:

Substances chimiques

Allergens 0
Dust 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-116

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Mario Olivieri (M)

Diagnostics and Public Health-Unit of Occupational Medicine, University of Verona, Verona, Italy mario.olivieri@univr.it.

Nicola Murgia (N)

Occupational Medicine, Respiratory Diseases and Toxicology, University of Perugia, Perugia, Italy.

Gianluca Spiteri (G)

Diagnostics and Public Health-Unit of Occupational Medicine, University of Verona, Verona, Italy.

Carlo Alberto Biscardo (CA)

Diagnostics and Public Health-Unit of Occupational Medicine, University of Verona, Verona, Italy.

Pierpaolo Marchetti (P)

Diagnostics and Public Health-Unit of Epidemiology and Medical Statistics, University of Verona, Verona, Italy.

Ilenia Folletti (I)

Clinical and Experimental Medicine, Occupational Medicine, University of Perugia, Terni, Italy.

Giuseppe Verlato (G)

Diagnostics and Public Health-Unit of Epidemiology and Medical Statistics, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH